Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Sun, Jian ^a   Luo, Yixi ^a   Tian, Zhen ^b   Gu, Liang ^a   Xia, Shu C ^a   Yu, Youcheng ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; ERBB3 BINDING PROTEIN 1; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; UVOMORULIN;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM SURVIVAL; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIGRATION INHIBITION; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVARY GLAND CARCINOMA; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CADHERINS; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; CELL MOVEMENT; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PARAFFIN EMBEDDING; RNA-BINDING PROTEINS; SALIVARY GLAND NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 84867898158     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-499     Document Type: Article

References (30)

1. Gondivkar SM, Gadbail AR, Chole R, Parikh RV. Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral Oncol 2011, 47:231-236. 10.1016/j.oraloncology.2011.01.009, 21353624.
2. Marchio C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). J Clin Pathol 2010, 63:220-228. 10.1136/jcp.2009.073908, 20203221.
3. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006, 42:759-769. 10.1016/j.oraloncology.2006.01.001, 16757203.
4. Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK. Molecular biology of adenoid cystic carcinoma. Head Neck 2011,
5. Yoo JY, Wang XW, Rishi AK, Lessor T, Xia XM, Gustafson TA, Hamburger AW. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer 2000, 82:683-690. 2363329, 10682683.
6. Zhang Y, Woodford N, Xia X, Hamburger AW. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acids Res 2003, 31:2168-2177. 10.1093/nar/gkg318, 153746, 12682367.
7. Zhang Y, Hamburger AW. Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription. J Biol Chem 2004, 279:26126-26133. 10.1074/jbc.M314305200, 15073182.
8. Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A, Hamburger AW. The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci U S A 2005, 102:9890-9895. 10.1073/pnas.0503829102, 1175001, 15994225.
9. Horvath BM, Magyar Z, Zhang Y, Hamburger AW, Bako L, Visser RG, Bachem CW, Bogre L. EBP1 regulates organ size through cell growth and proliferation in plants. EMBO J 2006, 25:4909-4920. 10.1038/sj.emboj.7601362, 1618091, 17024182.
10. Zhang Y, Lu Y, Zhou H, Lee M, Liu Z, Hassel BA, Hamburger AW. Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice. BMC Cell Biol 2008, 9:69. 10.1186/1471-2121-9-69, 2648959, 19094237.
11. Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H, Zhang Z. Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer. Int J Cancer 2007, 120:1909-1913. 10.1002/ijc.22541, 17266032.
12. Zhang Y, Linn D, Liu Z, Melamed J, Tavora F, Young CY, Burger AM, Hamburger AW. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Mol Cancer Ther 2008, 7:3176-3186. 10.1158/1535-7163.MCT-08-0526, 2629587, 18852121.
13. Zhang Y, Ali TZ, Zhou H, D'Souza DR, Lu Y, Jaffe J, Liu Z, Passaniti A, Hamburger AW. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res 2010, 70:240-248. 10.1158/0008-5472.CAN-09-2904, 20048076.
14. Hamburger AW. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies. J Mammary Gland Biol Neoplasia 2008, 13:225-233. 10.1007/s10911-008-9077-5, 18425425.
15. Barnes LEJ, Tufano RP, Sidransky D. WHO Classification of Tumors: Pathology and Genetics of the Head and Neck Tumors 2005, IARC Press, Lyon.
16. LHWC S TNM Classification of Malignant Tumors 2002, Wiley-Liss, New York, 6, LHWC S.
17. Ho YT, Yang JS, Li TC, Lin JJ, Lin JG, Lai KC, Ma CY, Wood WG, Chung JG. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett 2009, 279:155-162. 10.1016/j.canlet.2009.01.033, 19251361.
18. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011, 278:16-27. 10.1111/j.1742-4658.2010.07919.x, 21087457.
19. Luukkaa H, Klemi P, Hirsimaki P, Vahlberg T, Kivisaari A, Kahari VM, Grenman R. Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer. Acta Otolaryngol 2008, 128:482-490. 10.1080/00016480801922895, 18368586.
20. Nascimento CF, Gama-De-Souza LN, Freitas VM, Jaeger RG. Role of MMP9 on invadopodia formation in cells from adenoid cystic carcinoma. Study by laser scanning confocal microscopy. Microsc Res Tech 2010, 73:99-108.
21. Yang X, Dai J, Li T, Zhang P, Ma Q, Li Y, Zhou J, Lei D. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis. Oral Oncol 2010, 46:755-760. 10.1016/j.oraloncology.2010.08.008, 20850374.
22. Ishii K, Shimoda M, Sugiura T, Seki K, Takahashi M, Abe M, Matsuki R, Inoue Y, Shirasuna K. Involvement of epithelial-mesenchymal transition in adenoid cystic carcinoma metastasis. Int J Oncol 2011, 38:921-931.
23. Lessor TJ, Yoo JY, Xia X, Woodford N, Hamburger AW. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines. J Cell Physiol 2000, 183:321-329. 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O, 10797306.
24. Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004, 12:127-132. 10.1097/00020840-200404000-00013, 15167050.
25. Zhang Y, Fondell JD, Wang Q, Xia X, Cheng A, Lu ML, Hamburger AW. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Oncogene 2002, 21:5609-5618. 10.1038/sj.onc.1205638, 12165860.
26. Squatrito M, Mancino M, Donzelli M, Areces LB, Draetta GF. EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes. Oncogene 2004, 23:4454-4465. 10.1038/sj.onc.1207579, 15064750.
27. Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ, Stine OC. Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 2001, 61:6046-6049.
28. Bleijs DA, Geijtenbeek TB, Figdor CG, van Kooyk Y. DC-SIGN and LFA-1: a battle for ligand. Trends Immunol 2001, 22:457-463. 10.1016/S1471-4906(01)01974-3, 11473836.
29. Griffioen AW. Anti-angiogenesis: making the tumor vulnerable to the immune system. Cancer Immunol Immunother 2008, 57:1553-1558. 10.1007/s00262-008-0524-3, 2491426, 18438662.
30. Shirai A, Furukawa M, Yoshizaki T. Expression of intercellular adhesion molecule (ICAM)-1 in adenoid cystic carcinoma of the head and neck. Laryngoscope 2003, 113:1955-1960.